Journals / Acta Medica / 2020 / Cilt: 51 - Sayı: 4

Electrolyte Imbalance and Its Effect on QTc Interval in Patients Hospitalized with COVID-19

Pages
1–9
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

After treatment, a significant prolongation was observed in the QTc interval and a significant relationship was observed between QTc-AT and potassium levels, but no significant relationship with calcium was observed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Studies have shown that electrolyte abnormalities can be seen in Coronavirus disease 2019 (COVID-19) patients and are associated with the severity of the disease.
📊
Key Findings & Data:We aimed to investigate the electrolyte imbalance such as hypocalcemia and hypokalemia in patients hospitalized with COVID-19 and its effect on the QTc interval.
💡
Conclusion & Impact:After treatment, a significant prolongation was observed in the QTc interval and a significant relationship was observed between QTc-AT and potassium levels, but no significant relationship with calcium was observed.
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Özet

Objective: Studies have shown that electrolyte abnormalities can be seen in Coronavirus disease 2019 (COVID-19) patients and are associated with the severity of the disease. We aimed to investigate the electrolyte imbalance such as hypocalcemia and hypokalemia in patients hospitalized with COVID-19 and its effect on the QTc interval. Materials and Methods: 185 hospitalized patients with COVID-19 whose diagnosis was confirmed by a real-time reverse transcriptasepolymerase chain reaction and/or Computed Tomography of the chest were included in the study. The potassium and calcium measurements on the admission and third day of hospitalization were recorded. The QTc interval measurement was performed on the admission (QTc-B) and the 3rd-day (QTc-AT) electrocardiography. Results: The median age was 43 (31-56 IQR) and 102 (55.1%) of patients were male. Median baseline potassium level was 4.0 mEq/L (3.7-4.3 IQR) and corrected calcium level was 8.48 mg/dl (8.24-8.73 IQR), whereas the 3rd-day median potassium level was 4.2 mEq/L (3.9-4.5 IQR) and corrected calcium level was 8.42 mg/dl (8.16-8.70 IQR).The median QTc-B interval was found as 427 ms (409-447 IQR) whereas the median QTc-AT interval was found as 438 ms (414-459 IQR). Median 9 ms (-5- 28 IQR) prolongation was observed in the QTc interval, which was statistically significant (p <0.001). There was a significant relationship between QTc-AT and baseline potassium level, potassium level on the 3rd day (respectively β coefficient= -2.083, 95% CI -27.134- -0.577, p value= 0.041, β coefficient= -2.547, 95% CI -27.925 - -3.385, p value= 0,013 ) but there was no significant relationship with baseline and 3rd day calcium level. (respectively β coefficient= -0.848, 95% CI -22.102- 8.919, p value= 0.399, β coefficient= 0.707, 95% CI -8.685 - 20.784, p value= 0.415) Conclusion: Electrolyte disorders such as hypocalcemia and hypokalemia can be seen in patients hospitalized with COVID-19. After treatment, a significant prolongation was observed in the QTc interval and a significant relationship was observed between QTc-AT and potassium levels, but no significant relationship with calcium was observed.

🔖

Cite This Article

ÇAP, M., ALTINTAŞ, B., BİLGE, Ö., IŞIK, F., İNCİ, Ü., ALTINDAĞ, R., AKYÜZ, A., SÜLEYMANOĞLU, M., ARSLAN, B., KAYA, İ., ADIYAMAN, M. Ş., ALTINTAŞ, D. D., KANBAL, N., BAYSAL, E. (2020). Electrolyte Imbalance and Its Effect on QTc Interval in Patients Hospitalized with COVID-19. Acta Medica, Cilt: 51 - Sayı: 4, 1–9. https://ajindex.com/articles/207607

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020; 323: 1239-1242
  2. World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19—11 March 2020. https://www.who.int/dg/speeches/detail/ who-directorgeneral-s-opening-remarks-at-the-mediabriefing-on-covid19—11-march-2020. Accessed March 24, 2020
  3. World Health Organization. Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). https://www.who. int/news-room/detail/30-01-2020-statement-on-thesecond-meeting-of-theinternational-health-regulations- (2005)-emergency-committee-regarding-the-outbreakof-novel-coronavirus-(2019-ncov). Accessed March 24, 2020
  4. Madjid M, Safavi-Naeini P, Solomon SD, et al. Potential Effects of Coronaviruses on the Cardiovascular System: A Review. JAMA Cardiol. Published online March 27, 2020. doi:10.1001/jamacardio.2020.1286 [5] Straus SM, Kors JA, De Bruin ML, et al. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol. 2006; 47:362-7
  5. Zhang Y, Post WS, Dalal D, et al. QT-interval duration and mortality rate: results from the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2011; 171: 1727-33
  6. Beinart R, Zhang Y, Lima J, et al. The QT interval is associated with incident cardiovascular events: the MESA study. J Am Coll Cardiol. 2014; 64: 2111-9
  7. Chorin E, Wadhwani L, Magnani S, et al. QT Interval Prolongation and Torsade De Pointes in Patients with COVID-19 treated with Hydroxychloroquine/Azithromycin [published online ahead of print, 2020 May 11]. Heart Rhythm. 2020; S1547-5271(20)30435-5
  8. World Health Organization. The cardiotoxicity of antimalarials: Malaria Policy Advisory Committee Meeting. Published March 24, 2017. Accessed April 21, 2020. https://www.who.int/malaria/mpac/ mpac-mar2017-ergcardiotoxicity-report-session2.pdf [10] Ray WA, Murray KT, Hall et al. Azithromycin and the risk of cardiovascular death. N Engl J Med. 2012; 366(20): 1881- 1890
  9. Guan W-J, Ni Z-Y, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; 382: 1708-1720
  10. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2